US29772L1089
US29772L1089
Eton Pharmaceuticals, Inc.
Loading chart...
Pure Price Volatility Risk (Market Swings)
The business itself is financially solid (Financial Health 80/100, minimal insolvency risk). The high overall score (7/7) is driven primarily by extreme stock price swings (±66.2% p.a.) and steep historical drawdowns.
Volatility Risk
Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.
Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta
Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Largely moves in line with the broader market.
Beta (Market Relation)
0.9x
DefensiveVolatility (5Y p.a.)
66.2% p.a.
5-Year HorizonMax Drawdown (5Y)
-69.3%
5-Year HorizonSharpe Ratio
0.89
Return / RiskSpeculative / High Risk: Score Basis:
Multi-Horizon Risk & Performance Matrix
Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.
High Volatility
Timeframe | Volatility (p.a.) | Max Drawdown | Sharpe Ratio | Return (p.a.) |
|---|---|---|---|---|
| 1 Year | — | — | — | +161.6% |
| 3 Years | 64.2% | -39.2% | 2.08 | +135.9% |
| 5 Years | 66.2% | -69.3% | 0.89 | +61.5% |
| 10 Years | 65.5% | -79.9% | 0.44 | — |
Automated Risk & Health Notes (Red Flags)
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 High valuation risk: Avg P/E of 138.0 (Elevated multiple compression risk)
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (66.2% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -79.9% in the extended horizon.
Corporate Governance & ISS Scores
Overall Governance Risk
8 ISS Score: 8 / 10
Audit Risk
5 ISS Score: 5 / 10
Board Risk
8 ISS Score: 8 / 10
Short Ratio
2.70